The LM Brief: Conditional Voting Rights in VC Term Sheets
This week’s World of DaaS LM Brief looks at a recent piece by Auren Hoffman, co-authored with Sushant Bhardwaj and Lily Petherick from Flex Capital, on a little-known but impactful clause in VC term sheets that can strip founders of their voting rights when they leave their company.
We cover how th…
BRAVE: VC Term Sheets VS. Founder Control, Valuation Myths, Governance & Deal Failure - E663
Jeremy Au breaks down how venture capital deals really close, why many fail after the term sheet, and how financial and control rights shape outcomes for founders and investors over a 10-year relationship. Drawing from real cases across Southeast Asia, he explains the hidden trade-offs behind valua…
Deep Dive: VC Term Sheets with Siddharth Mody
In this episode you will learn:
What is a term sheet and why does it exist?
What are the key sections of a term sheet?
Why is the term sheet less like a legal document and more like a commercial document?
Do you need a lawyer to negotiate the term sheets that VCs offer startups when they’re raisi…
VC Money Tight? Here’s How Startups Still Land Top Talent (2025)
What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive recruiter William Holodnak (ex-Fidelity, global biotech headhunter) breaks down 2025’s wild hiring market—and how founder…
🧬 Stephanie Sirota - RTW Investments - Part 1 | Early Influences on Leadership Style | Competitive Tennis Fosters Professional Drive | The Inverse Importance of Coaching | The Ending of a Dream to Open New Doors | Organically Choosing Your Track
Part 1 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development,…
🧬 Kittu Kolluri - Neotribe Ventures - Part 3 | Influence vs Control as a VC | Being a Leader in Venture vs a Leader in a Company | Starting Neotribe as a Passionate Rage Against the Status Quo | Sunk Cost vs Opportunity Cost | Optimizing Customer Acquisit
Part 3 of 3. My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of se…
🧬 Stephanie Sirota - RTW Investments - Part 3 | The Emergence of Crossover Rounds | Building & Explaining Your Investment Thesis | Creating a .600 Batting Average Investment Fund | Transparency Between Investor & Founder | How to Get LPs to Say “Yes”
Part 3 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development,…
🧬 Stephanie Sirota - RTW Investments - Part 2 | Understanding Investment Banking’s Role in the Biosciences | Finding the Benefits of Your Uniqueness | Unexpected Pivots & Finding Passion in Your Work | Advice on Dealing with Bear Markets
Part 2 of 3. My guest for this week’s episode is Stephanie Sirota, Partner, and Chief Business Officer at RTW Investments, a full lifecycle life sciences investment firm dedicated to solving the most challenging unmet patient needs. Stephanie is a seasoned expert and leader in business development,…
🧬 Sandy Paige - Seabright Ventures Fund - Part 1 | The Value of Hustle & Being a Team Player | Saying Yes to Opportunities | Corporate Entrepreneurship & Finding Your Path | Entrepreneurs & Risk Aversion
Part 1 of 4. My guest for this week’s episode is Sandy Paige, co-managing director of the Seabright Ventures Fund, a search fund investing in the US middle market, with a focus on life sciences and cleantech. Sandy is an expert CEO, most recently leading and scaling Explora BioLabs before its acqui…
🧬 Doug Drysdale - Cybin - Part 2 | Deals Only Get Done in Person | Learning Financing Through a Company’s Hardship | Bureaucracy in the Workplace | How to Educate Yourself to Determine Good Licensing Deals
Part 2 of 4.
My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create safe and effective psychedelic-based therapeutics. Their goal is to address the large unmet need for new and innovative treatment options for people who…
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,823,486و قسمت های195,632,518بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
